search
Back to results

The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block

Primary Purpose

Gastrointestinal Disease

Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Ropivacaine injection
Sponsored by
Zhujiang Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gastrointestinal Disease focused on measuring Acute gastrointestinal injury, Erector spinal muscle plane block, Ropivacaine

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. AGI are diagnosed according to the diagnostic criteria proposed by European Society Intensive Care Medicine (ESICM) in 2012 and the AGI grade great than or equal to II.
  2. Age 18-80 years.
  3. Expected length of stay longer than 3 days.

Exclusion Criteria:

  1. Mean arterial pressure is still less than 65 millimeter of Mercury (mmHg) treated with rehydration and vasoactive agents, or with the dosage of norepinephrine more than 0.5ug/kg/min.
  2. Heart rates are less than 50 beats per minute or moderate and severe atrioventricular block without pacemaker.
  3. Primary gastrointestinal disease such as mechanical intestinal obstruction, massive hemorrhage of gastrointestinal tract and gastrointestinal perforation.
  4. Severe trauma of chest, abdomen or back. gastrointestinal tract surgery history.
  5. Neuromuscular disorders.
  6. Drug addiction, alcohol abuse, opioid or amphetamine dependence, or mental disorders.
  7. Pregnancy.
  8. Brain dead.
  9. Malignant tumor, or end-stage cachexia.
  10. With contraindications of the erector spinae plane block (ESPB), such as local infection, Spinal diseases or immobilization.
  11. Allergy to local anesthetics.
  12. Significant abnormalities in blood coagulation parameters.
  13. Without written informed consent.

Sites / Locations

  • Zhujiang Hospital of Southern Medical University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Experimental Group

Controlled Group

Arm Description

On the basis of the clinical routine treatment of AGI in severe patients, the Experimental Group will receives ultrasound-guided erector spinae plane block with routine treatment of AGI for 7 days or until transferring to the general ward.

the routine clinical treatment of AGI is given to severe patients, such as gastrointestinal dynamic drugs, traditional Chinese drugs and physical rehabilitation therapy

Outcomes

Primary Outcome Measures

the cure rate of AGI
the cure rate of AGI on the day3
the cure rate of AGI
the cure rate of AGI on the day7
the remission rate of AGI
the remission rate of AGI on the day3
the remission rate of AGI
the remission rate of AGI on the day7

Secondary Outcome Measures

Acute Physiology and Chronic Health Evaluation(APACHE II)
measuring endpoints include: body temperature mean arterial pressure (MAP) heart rate (HR) respiratory rate (RR) fraction of inspiration O2 (FIO2) potential of hydrogen (PH) Na+ K+ serum creatinine (SCr) hematocrit (Hct%) white blood cell (WBC) Age immunosuppression before/after surgery or serious organ dysfunction (Higher score means a worse outcome.)
Organ dysfunction assessed by Sequential Organ Failure Assessment (SOFA) score
SOFA score evaluate status of the following organ systems separately: (Higher score means a worse outcome.) Respiration Partial Pressure of Oxygen/Fraction of Inspiration O2 (PaO2/FiO2) Coagulation Platelets Liver Bilirubin Circulatory Mean arterial pressure Central Nervous System Glasgow coma score Renal Creatinine (or urine output)
the intraperitoneal pressure(IAP)
Gastrointestinal function indicators
abdominal perfusion pressure(AAP)
Gastrointestinal function indicators
total gastric residual volume(GRVs)
Gastrointestinal function indicators
feeding dose
Gastrointestinal function indicators
Gastrointestinal dysfunction and duration(GIF)
fasting(score 1 point) reflux(score 2 points) gastrointestinal decompression(1 point) Gastric retention(2 points) abdominal distension(2 points) abdominal pain(2 points) diarrhea(2 points) hypoactive bowel sounds(1 point) bowel sounds disappear(2 points) constipation(2 points) The mentioned indicators will be combined to report GIF in score. Grade 0 (Normal) : 0 score Grade 1 (Mild) : 1~4 score Grade 2 (Medium) : 5~9 score Grade 3 (Serious) : >10 score
Width of the colons
width of the right colons with abdominal X ray or CT
White Blood Cell(WBC)
The inflammatory indicators
Interleukin-6(IL-6)
The inflammatory indicators
Cross-sectional area of pyloric antrum(AS)
cross-sectional area of pyloric antrum(AS) with ultrasound
Lymphocyte (LYM)
The inflammatory indicators
Neutral Granular Cell(NEUT)
The inflammatory indicators
Procalcitonin (PCT)
The inflammatory indicators
Hypersensitive C Reactive Protein(HSCRP)
The inflammatory indicators
The lactic acid(Lac)
the serum level of the lactic
The 28-day mortality
the 28-day mortality
The length of stay in ICU
From the date of ICU admission to transfered out.
The total days of hospitalization
from hospital admission to hospital discharge.

Full Information

First Posted
June 3, 2021
Last Updated
September 8, 2022
Sponsor
Zhujiang Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04934904
Brief Title
The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block
Official Title
The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block - a Prospective, Single-center, Randomized, Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
August 1, 2019 (Actual)
Primary Completion Date
August 23, 2021 (Actual)
Study Completion Date
September 15, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Zhujiang Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In this single-center, randomized, parallel control clinical trial, patients will be randomly assigned to two groups. The treatment group receives ultrasound-guided erector spinae plane block with routine treatment of Acute Gastrointestinal Injury (AGI) for 7 days or until transferred to the general ward, while the control group only receives routine treatment of AGI. The primary outcome is the cure and remission rate of AGI.
Detailed Description
Detailed Description: Study title: The treatment of Acute Gastrointestinal Injury via ultrasound-guided erector spinae plane block - a prospective, single-center, randomized, controlled trial Principal Investigator: Professor Wang Hua, Department of Critical Care Unit, Zhujiang Hospital of Southern Medical University Study subjects: Patients age from 18 to 80 with AGI Ⅱ or greater Study phase: Investigator Initiated Trial(IIT) Primary objectives: To evaluate whether ultrasound-guided erector spinae plane block can reduce the grade of AGI , and improve the cure and remission rate of AGI. Experimental Group: On the basis of routine clinical treatment, the ultrasound-guided erector spinae plane block intervention is given. On the first day enrolled, patients are performed with ultrasound-guided erector spinae plane block and cannula will be placed on T8 bilaterally. 0.375% ropivacaine of 20ml is injected separately to both sides with 2ml per hour. Injection is performed twice a day for 7 days or until transferred to the general ward. Controlled Group: The patients will receive the clinical routine treatment according of AGI recommended by the 2012 European Society of Critical Care Medicine guidelines, with a uniform nutritional strategy(gastrointestinal dynamic drugs, traditional Chinese drugs and physical rehabilitation therapy). Course: 7 days Sample size: 100 Sites: 1 Primary endpoints: the cure rate of AGI the remission rate of AGI Secondary endpoints: critical ill scores Gastrointestinal function indicators The inflammatory indicators the lactic acid(Lac) cross-sectional area of pyloric antrum(AS) with ultrasound width of the colons with abdominal X ray or CT the 28-day mortality gastrointestinal dysfunction and duration (GIF) Additional endpoints: The length of stay in ICU The total days of hospitalization

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastrointestinal Disease
Keywords
Acute gastrointestinal injury, Erector spinal muscle plane block, Ropivacaine

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Experimental Group: On the basis of the clinical routine treatment of AGI in severe patients (gastrointestinal dynamic drugs, traditional Chinese drugs and physical rehabilitation therapy), the ultrasound-guided erector spinae plane block intervention is given. Controlled Group: Normal Treatment.
Masking
None (Open Label)
Masking Description
This study adopted a randomized, open, blank control design, and did not blind researchers, patients or clinicians.
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental Group
Arm Type
Experimental
Arm Description
On the basis of the clinical routine treatment of AGI in severe patients, the Experimental Group will receives ultrasound-guided erector spinae plane block with routine treatment of AGI for 7 days or until transferring to the general ward.
Arm Title
Controlled Group
Arm Type
No Intervention
Arm Description
the routine clinical treatment of AGI is given to severe patients, such as gastrointestinal dynamic drugs, traditional Chinese drugs and physical rehabilitation therapy
Intervention Type
Drug
Intervention Name(s)
Ropivacaine injection
Other Intervention Name(s)
ropivacaine
Intervention Description
On the first day of inclusion, performed T8 bilateral ultrasound-guided erector spinae plane block and indwelling tube will be left + 0.375% ropivacaine 20ml to both sides. Patients will be given injections every 12 h for 7 days.
Primary Outcome Measure Information:
Title
the cure rate of AGI
Description
the cure rate of AGI on the day3
Time Frame
on the day3
Title
the cure rate of AGI
Description
the cure rate of AGI on the day7
Time Frame
on the day7
Title
the remission rate of AGI
Description
the remission rate of AGI on the day3
Time Frame
on the day3
Title
the remission rate of AGI
Description
the remission rate of AGI on the day7
Time Frame
on the day7
Secondary Outcome Measure Information:
Title
Acute Physiology and Chronic Health Evaluation(APACHE II)
Description
measuring endpoints include: body temperature mean arterial pressure (MAP) heart rate (HR) respiratory rate (RR) fraction of inspiration O2 (FIO2) potential of hydrogen (PH) Na+ K+ serum creatinine (SCr) hematocrit (Hct%) white blood cell (WBC) Age immunosuppression before/after surgery or serious organ dysfunction (Higher score means a worse outcome.)
Time Frame
on the day 0,1,3 and 7
Title
Organ dysfunction assessed by Sequential Organ Failure Assessment (SOFA) score
Description
SOFA score evaluate status of the following organ systems separately: (Higher score means a worse outcome.) Respiration Partial Pressure of Oxygen/Fraction of Inspiration O2 (PaO2/FiO2) Coagulation Platelets Liver Bilirubin Circulatory Mean arterial pressure Central Nervous System Glasgow coma score Renal Creatinine (or urine output)
Time Frame
on the day 0,1,3 and 7
Title
the intraperitoneal pressure(IAP)
Description
Gastrointestinal function indicators
Time Frame
on the day 0,1,3 and 7
Title
abdominal perfusion pressure(AAP)
Description
Gastrointestinal function indicators
Time Frame
on the day 0,1,3 and 7
Title
total gastric residual volume(GRVs)
Description
Gastrointestinal function indicators
Time Frame
on the day 0,1,3 and 7
Title
feeding dose
Description
Gastrointestinal function indicators
Time Frame
on the day 0,1,3 and 7
Title
Gastrointestinal dysfunction and duration(GIF)
Description
fasting(score 1 point) reflux(score 2 points) gastrointestinal decompression(1 point) Gastric retention(2 points) abdominal distension(2 points) abdominal pain(2 points) diarrhea(2 points) hypoactive bowel sounds(1 point) bowel sounds disappear(2 points) constipation(2 points) The mentioned indicators will be combined to report GIF in score. Grade 0 (Normal) : 0 score Grade 1 (Mild) : 1~4 score Grade 2 (Medium) : 5~9 score Grade 3 (Serious) : >10 score
Time Frame
on the day 0,1,3 and 7
Title
Width of the colons
Description
width of the right colons with abdominal X ray or CT
Time Frame
on the day 0,1,3 and 7
Title
White Blood Cell(WBC)
Description
The inflammatory indicators
Time Frame
on the day 0,1,3 and 7
Title
Interleukin-6(IL-6)
Description
The inflammatory indicators
Time Frame
on the day 0,1,3 and 7
Title
Cross-sectional area of pyloric antrum(AS)
Description
cross-sectional area of pyloric antrum(AS) with ultrasound
Time Frame
on the day 0,1,3 and 7
Title
Lymphocyte (LYM)
Description
The inflammatory indicators
Time Frame
on the day 0,1,3 and 7
Title
Neutral Granular Cell(NEUT)
Description
The inflammatory indicators
Time Frame
on the day 0,1,3 and 7
Title
Procalcitonin (PCT)
Description
The inflammatory indicators
Time Frame
on the day 0,1,3 and 7
Title
Hypersensitive C Reactive Protein(HSCRP)
Description
The inflammatory indicators
Time Frame
on the day 0,1,3 and 7
Title
The lactic acid(Lac)
Description
the serum level of the lactic
Time Frame
on the day 0,1,3 and 7
Title
The 28-day mortality
Description
the 28-day mortality
Time Frame
From enrolled to 28 days or the termination date
Title
The length of stay in ICU
Description
From the date of ICU admission to transfered out.
Time Frame
on the day 28 or through study completion
Title
The total days of hospitalization
Description
from hospital admission to hospital discharge.
Time Frame
on the day 28 or through study completion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: AGI are diagnosed according to the diagnostic criteria proposed by European Society Intensive Care Medicine (ESICM) in 2012 and the AGI grade great than or equal to II. Age 18-80 years. Expected length of stay longer than 3 days. Exclusion Criteria: Mean arterial pressure is still less than 65 millimeter of Mercury (mmHg) treated with rehydration and vasoactive agents, or with the dosage of norepinephrine more than 0.5ug/kg/min. Heart rates are less than 50 beats per minute or moderate and severe atrioventricular block without pacemaker. Primary gastrointestinal disease such as mechanical intestinal obstruction, massive hemorrhage of gastrointestinal tract and gastrointestinal perforation. Severe trauma of chest, abdomen or back. gastrointestinal tract surgery history. Neuromuscular disorders. Drug addiction, alcohol abuse, opioid or amphetamine dependence, or mental disorders. Pregnancy. Brain dead. Malignant tumor, or end-stage cachexia. With contraindications of the erector spinae plane block (ESPB), such as local infection, Spinal diseases or immobilization. Allergy to local anesthetics. Significant abnormalities in blood coagulation parameters. Without written informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hua Wang, MD,PhD
Organizational Affiliation
Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zhujiang Hospital of Southern Medical University
City
Guangzhou
State/Province
Guangdong
ZIP/Postal Code
510280
Country
China

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Treatment of Acute Gastrointestinal Injury Via Ultrasound-guided Erector Spinae Plane Block

We'll reach out to this number within 24 hrs